Related Experiment Video
Updated: Jun 4, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of
Ruth Dubin1, Mary Cushman, Aaron R Folsom
1Department of Medicine, Division Nephrology, University of California San Francisco, 521 Parnassus Avenue, San Francisco, CA 94143-0532, USA. ruth.dubin@ucsf.edu
Insights
Reduced kidney function (eGFR < 60) is linked to higher levels of blood clotting markers (hemostasis). This dysregulation may explain the increased cardiovascular risk associated with chronic kidney disease (CKD).
Area of Science:
- Nephrology and Cardiovascular Research
- Hemostasis and Thrombosis
- Epidemiology of Chronic Diseases
Background:
- Chronic kidney disease (CKD), defined by estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2, is a significant independent risk factor for cardiovascular and overall mortality.
- A potential link between impaired kidney function and hemostatic system abnormalities was hypothesized.
Purpose of the Study:
- To investigate the association between reduced kidney function (eGFR) and various hemostatic markers.
- To explore potential mechanisms linking CKD to increased cardiovascular risk through hemostatic dysregulation.
Main Methods:
- Cross-sectional analysis of 6751 participants from the Multi-Ethnic Study of Atherosclerosis (MESA) with a wide range of kidney function.
- Kidney function assessed using cystatin C (eGFRcys) and creatinine (eGFRcr).
- Measured hemostatic markers included sTM, sTF, D-Dimer, vWF, Factor VIII, PAP, TFPI, PAI-1, and fibrinogen, analyzed via multivariable linear regression.
Main Results:
- Participants with lower eGFRcys (< 60 ml/min/1.73 m2) exhibited significantly higher adjusted levels of multiple hemostatic markers compared to those with eGFRcys >90.
- Elevated levels were observed for sTM (86%), sTF (68%), D-Dimer (44%), PAP (22%), Factor VIII (17%), TFPI (15%), vWF (12%), and fibrinogen (6%).
- Similar trends were noted for individuals with moderate kidney dysfunction (eGFRcys 60-90), with no significant differences when categorized by eGFRcr.
Conclusions:
- A consistent association exists between lower eGFR and elevated hemostatic marker levels across a broad spectrum of kidney function.
- Dysregulation of the hemostatic system is a potential contributing mechanism for the heightened cardiovascular risk observed in individuals with reduced kidney function.
Background:
Defined as estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2, chronic kidney disease (CKD) is strongly and independently associated with cardiovascular and overall mortality. We hypothesized that reduced kidney function would be characterized by abnormalities of hemostasis.
Methods:
We tested cross-sectional associations between (eGFR) and multiple hemostatic markers among 6751 participants representing a broad spectrum of kidney function in the Multi-Ethnic Study of Atherosclerosis (MESA). Kidney function was measured using cystatin C (eGFRcys) or creatinine, using CKD Epidemiology Collaboration (eGFRcr). Hemostatic markers included soluble thrombomodulin (sTM), soluble tissue factor (sTF), D-Dimer, von Willebrand factor (vWF), factor VIII, plasmin-antiplasmin complex (PAP), tissue factor pathway inhibitor (TFPI), plasminogen activator inhibitor-1 (PAI-1), and fibrinogen. Associations were tested using multivariable linear regression with adjustment for demographics and comorbidities.
Results:
In comparison to persons with eGFRcys >90 ml/min/1.73 m2, subjects with eGFRcys < 60 ml/min/1.73 m2 had adjusted levels of sTM, sTF, D-Dimer, PAP, Factor VIII, TFPI, vWF and fibrinogen that were respectively 86%, 68%, 44%, 22%, 17%, 15%, 12% and 6% higher. Subjects with eGFRcys 60-90 ml/min/1.73 m2 had adjusted levels that were respectively 16%, 14%, 12%, 6%, 6%, 6%, 11% and 4% higher (p < 0.05 for all). Percent differences were not significantly different when groups were categorized by eGFRcr.
Conclusions:
Throughout a broad spectrum of kidney function, lower eGFR was associated with higher levels of hemostatic markers. Dysregulation of hemostasis may be a mechanism by which reduced kidney function promotes higher cardiovascular risk.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Imaging Studies VII: Vascular Imaging
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
